EASL Congress 2023 logo web

Overview

What you can expect at EASL Congress 2023

What you can expect at EASL Congress 2023

Everything you need to know about the liver in 2023 and beyond! Hepatology is diverse and so is the programme at EASL 2023. Different specialities, different levels of expertise, different backgrounds – EASL Congress 2023 has got you covered  

Everything you need to know about the liver in 2023 and beyond! Hepatology is diverse and so is the programme at EASL 2023. Different specialities, different levels of expertise, different backgrounds – EASL Congress 2023 has got you covered  

EASL Congress 2023 – keeping on track! 

Dedicated symposia, pros & cons debates, case-based discussions, workshops and Meet the Expert sessions will provide you with State-of-the-Art education on hepatology and liver biology. Oral abstract sessions, poster tours and poster presentations will deliver you the latest research updates in the field.

EASL Congress 2023 – keeping on track! 

Dedicated symposia, pros & cons debates, case-based discussions, workshops and Meet the Expert sessions will provide you with State-of-the-Art education on hepatology and liver biology. Oral abstract sessions, poster tours and poster presentations will deliver you the latest research updates in the field.

Discover what to expect at the eight topic tracks:

The basic science track will cover the latest updates on mechanisms and treatment targets for different liver diseases. You will have a chance to learn more and update yourself on the many topics including extracellular vesicles in liver pathology, the role of miRNA/lncRNA in liver disease and basic and translational regenerative hepatology.
This track is a must for all health professionals dedicated to the management of patients with cirrhosis and advanced chronic liver disease. You can look forward to a very interactive program on all the new findings from basic to clinical research in cirrhosis, hands-on session on hepatology techniques. Attending the sessions is your opportunity to discuss with leaders in the field and a great networking environment.
Attending the sessions on general hepatology will provide you with the latest updates in the management, treatment, and diagnosis of liver disease. Focussed sessions will be on nutrition in liver disease, liver transplantation and AI in hepatology. The latest, best-rated articles published in top of their filed journals, includingin the EASL Journal of Hepatology will be presented and discussed. Intimate workshop sessions will offer authors advise on how to enhance their skills and careers.

The field of immune-mediated liver diseases is facing a very optimistic moment. Indeed, data from large international datasets have been key for the knowledge of natural history. Predictive factors of rare diseases and innovative basic science studies are leading to the development of new therapies for orphan diseases. This year’s programme focuses on personalised clinical management for patients that have more than one therapeutic option for the first time.

In the field of primary liver cancer, the EASL congress puts you at the forefront of research, development, and strategies for treating liver cancer patients. The combined expertise of hepatologists, surgeons, radiologists, biologists, nurses and patient organisations makes sure that you get a 360 degree overview on the latest about hepatocellular carcinoma and cholangio carcinoma from basic research to curative and systemic treatments.

The metabolism, alcohol and toxicity programme will be rich and stimulating, with important content for clinical practice, including an update on the available therapeutic landscape of NAFLD and how to manage patients with ALD globally. It will also cover the latest research highlights and how they contribute to a better understanding, future prevention, diagnosis, and clinical decision-making of both diseases.

With a broad range of clinical courses and outcomes, viral hepatitis remains a major global health burden and the road to eliminating viral hepatitis as an important cause of morbidity and mortality worldwide is full of obstacles. We will be discussing how the treatment landscape of viral hepatitis has changed and what the immediate future brings. The most recent data on the potentially causative agents for hepatitis will be critically discussed to expand the spectrum of viruses that need to be considered in patients with hepatitis.
The Public Health sessions will address the burden of liver disease on a European landscape of risk factors. A particular focus will be placed on alcohol and metabolic liver diseases and the urgent need for screening and prevention as well as the road to elimination of Viral hepatitis.

Discover what to expect at the eight topic tracks:

The basic science track will cover the latest updates on mechanisms and treatment targets for different liver diseases. You will have a chance to learn more and update yourself on the many topics including extracellular vesicles in liver pathology, the role of miRNA/lncRNA in liver disease and basic and translational regenerative hepatology.

This track is a must for all health professionals dedicated to the management of patients with cirrhosis and advanced chronic liver disease. You can look forward to a very interactive program on all the new findings from basic to clinical research in cirrhosis, hands-on session on hepatology techniques. Attending the sessions is your opportunity to discuss with leaders in the field and a great networking environment.

Attending the sessions on general hepatology will provide you with the latest updates in the management, treatment, and diagnosis of liver disease. Focussed sessions will be on nutrition in liver disease, liver transplantation and AI in hepatology. The latest, best-rated articles published in top of their filed journals, includingin the EASL Journal of Hepatology will be presented and discussed. Intimate workshop sessions will offer authors advise on how to enhance their skills and careers.

The field of immune-mediated liver diseases is facing a very optimistic moment. Indeed, data from large international datasets have been key for the knowledge of natural history. Predictive factors of rare diseases and innovative basic science studies are leading to the development of new therapies for orphan diseases. This year’s programme focuses on personalised clinical management for patients that have more than one therapeutic option for the first time.

In the field of primary liver cancer, the EASL congress puts you at the forefront of research, development, and strategies for treating liver cancer patients. The combined expertise of hepatologists, surgeons, radiologists, biologists, nurses and patient organisations makes sure that you get a 360 degree overview on the latest about hepatocellular carcinoma and cholangio carcinoma from basic research to curative and systemic treatments.

The metabolism, alcohol and toxicity programme will be rich and stimulating, with important content for clinical practice, including an update on the available therapeutic landscape of NAFLD and how to manage patients with ALD globally. It will also cover the latest research highlights and how they contribute to a better understanding, future prevention, diagnosis, and clinical decision-making of both diseases.

With a broad range of clinical courses and outcomes, viral hepatitis remains a major global health burden and the road to eliminating viral hepatitis as an important cause of morbidity and mortality worldwide is full of obstacles. We will be discussing how the treatment landscape of viral hepatitis has changed and what the immediate future brings. The most recent data on the potentially causative agents for hepatitis will be critically discussed to expand the spectrum of viruses that need to be considered in patients with hepatitis.

The Public Health sessions will address the burden of liver disease on a European landscape of risk factors. A particular focus will be placed on alcohol and metabolic liver diseases and the urgent need for screening and prevention as well as the road to elimination of Viral hepatitis.

Special formats to enhance your experience and boost your knowledge

Special formats to enhance your experience and boost your knowledge

Postgraduate Course
and
Basic Science Seminar

The first day of the congress starts with two highlights: The Postgraduate Course and the Basic Science Seminar. This year’s theme for the PGC is “From NAFLD to Liver Cancer” and “Inter-organ communication in liver disease” for the Basic Science Seminar.

From NAFLD to Liver Cancer

This year the Postgraduate Course will give you an overview of the molecular pathogenesis of NAFLD, NASH, and liver cancer. Through case studies learn more about the risk factors, prevention, and treatment of NAFLD, and in various sessions, hear about techniques used to manage liver cancer in these patients.

Inter-organ communication in liver disease 

The seminar aims to foster interaction between leaders-in-the-field and the audience. It contains multiple short duo-lectures, with first a more general ten-minute overview of the topic, followed by a more in-depth ten-minute presentation by a talented fellow, and finally an extensive Q&A with the audience.

Hands on
at the
Skills Learning Centre!

Roll up your sleeves, attend the Skills Learning Centre! Hands on courses – improve your practical skills.

The space is limited to 30 participants, registration is mandatory.
Meet the Experts
International Liver Congress 2022, London, United Kingdom
Photo©Steve Forrest/EASL

Don’t be afraid to ask

Meet the Expert!

The most popular session type at the EASL Congress! Be one of the 50 specialists who will Meet the Expert on the field in an informal way. Do you want to discuss a case or deep dive into a topic?

Then you need to attend one of the 24 Meet the Expert sessions.


The space is limited to 50 participants, registration is mandatory.

Postgraduate Course
and
Basic Science Seminar

The first day of the congress starts with two highlights: The Postgraduate Course and the Basic Science Seminar. This year’s theme for the PGC is “From NAFLD to Liver Cancer” and “Inter-organ communication in liver disease” for the Basic Science Seminar.

From NAFLD to Liver Cancer


This year the Postgraduate Course will give you an overview of the molecular pathogenesis of NAFLD, NASH, and liver cancer. Through case studies learn more about the risk factors, prevention, and treatment of NAFLD, and in various sessions, hear about techniques used to manage liver cancer in these patients.

Inter-organ communication in liver disease


The seminar aims to foster interaction between leaders-in-the-field and the audience. It contains multiple short duo-lectures, with first a more general ten-minute overview of the topic, followed by a more in-depth ten-minute presentation by a talented fellow, and finally an extensive Q&A with the audience.

Hands on
at the
Skills Learning Centre!

Roll up your sleeves, attend the Skills Learning Centre! Hands on courses – improve your practical skills.

The space is limited to 30 participants, registration is mandatory.

Don’t be afraid to ask

Meet the Expert!

The most popular session type at the EASL Congress! Be one of the 50 specialists who will Meet the Expert on the field in an informal way.

Do you want to discuss a case or deep dive into a topic?

Then you need to attend one of the 24 Meet the Expert sessions.


The space is limited to 50 participants, registration is mandatory.

Connect with us

This event is organised by EASL. Be careful to avoid non-official websites that may appear as EASL partners!

This event is organised by EASL.
Be careful to avoid non-official websites that may appear as EASL partners!

© 2022 EASL. All rights reserved.